TrialPanorama/TrialPanorama-database huggingface dataset:
Study: NCT03438552

Intervention type: RADIATION
Group type: EXPERIMENTAL
Intervention: Stereotactic Body Radiotherapy
Description: This radiotherapy may be administered with the CyberKnife® or a linear accelerator allowing stereotactic radiotherapy.

Intervention type: RADIATION
Group type: EXPERIMENTAL
Intervention: Stereotactic Body Radiotherapy
Description: This radiotherapy may be administered with the CyberKnife® or a linear accelerator allowing stereotactic radiotherapy.

Intervention type: RADIATION
Group type: EXPERIMENTAL
Intervention: Stereotactic Body Radiotherapy
Description: This radiotherapy may be administered with the CyberKnife® or a linear accelerator allowing stereotactic radiotherapy.
Study: NCT02014376

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: SD-101 dermal cream (3%)
Description: SD-101 is a white, crystalline powder that is formulated within an odorless, soft, white cream base. SD-101-3.0 cream contains allantoin, a diureide glyoxylic acid, at a concentration of 3% and other excipients.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: SD-101 Dermal Cream (6%)
Description: SD-101 is a white, crystalline powder that is formulated within an odorless, soft, white cream base. SD-101-6.0 cream contains allantoin, a diureide glyoxylic acid, at a concentration of 6% and other excipients.

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Vehicle (SD-101 0%)
Description: A white, crystalline powder that is formulated within an odorless, soft, white cream base. It contains no allantoin, only excipients.
Study: NCT00949195

Intervention type: OTHER
Intervention: Pulmonary pressure response during exercise
Description: Semi-supine echocardiography test
Study: NCT02919111

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Ga-68 labeled PSMA-11 PET
Description: Patients will be imaged using Ga-68 labeled PSMA-11 PET to determine if the presence of metastatic disease. Prostate Specific Membrane Antigen (PSMA) is a protein expressed on prostate cancer cells that can be imaged using small molecules that target this protocol.
Study: NCT04384146

Intervention type: RADIATION
Group type: EXPERIMENTAL
Intervention: Cyclical Hypofractionated Palliative Radiation (Quad Shot)
Description: 3.7 Gy twice daily x 2 days for a total dose of 14.8 Gy per cycle. The next cycle will occur after a 21-28 day break.

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: EORTC QLQ-C30 questionnaire
Description: at baseline, each cycle of Quad Shot, and at 3 weeks, 3 months and 6 months after last cycle of Quad Shot.
Study: NCT01531335

Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Hypocaloric hyperproteic nutrition
Description: 15 kcal per kg of body weight and 1.7 grams of protein per kg.

Intervention type: DIETARY_SUPPLEMENT
Group type: ACTIVE_COMPARATOR
Intervention: Standard care
Description: 25 kcal per kg of body weight
Study: NCT04017312

Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: High Frequency Chest Wall Oscillation
Description: High frequency chest wall oscillation (HFCWO) therapy (also known as high-frequency chest-wall compression or HFCWC) is commonly prescribed to provide routine airway clearance in patients with bronchiectasis as well as other patients with a need for regular airway clearance therapy. HFCWO generates high velocity expiratory airflow. This airflow is thought to mobilize secretions by the sheer force created, effecting changes in rheology and moving mucus in a cephalad direction during the oscillation. The Vest® Airway Clearance System, a commonly used device, generates HFCWO using an air pulse generator and an inflatable garment that delivers pressure pulses to the thorax. These pressure pulses within the garment create HFCWO.

Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Oscillating Positive Expiratory Pressure (OPEP)
Description: Oscillating PEP is an airway clearance technique, where the person blows all the way out many times through a device. These types of oscillating PEP devices work in two ways. Firstly, they use resistance to make it more difficult during the breath out, like non-oscillating PEP devices. Oscillating PEP devices also create vibrations when breathing out. The vibrations move mucus from the surface of the airways. After blowing through the device several times, the person will huff and cough to clear the mucus from the lungs.
Study: NCT04452916

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Buchinger fasting
Description: Caloric intake of \< 250 kcal/d for 5 days

Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Buchinger fasting
Description: Caloric intake of \< 250 kcal/d for 5 days
Study: NCT00829868

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Zaleplon 10 mg Capsules
Description: 1 x 10 mg

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: SONATA® 10 mg capsules
Description: 1 x 10 mg
Study: NCT01446523

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: placebo
Description: Syrup, 30 ml BD for 3 months in Gr. NL

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Lactulose
Description: Syrup 30 ml BD for 12 weeks
Study: NCT03697447

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Endermotherapy
Description: Endermotherapy massage (mechanic massage) of burn scar
Study: NCT02978521

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Pulmonary rehabilitation
Description: Session 1: ventilatory pattern training Session 2,3: ventilatory pattern + respiratory training with incentive spirometer Session 4-6: Sessions 1-3 training continues + training with Positive expiratory pressure device (Threshold PEP) and breathing trainer Threshold IMT) Sessions 7-9: Continue respiratory training + resistance training with RECK MOTOmed2 ergometer at a 30% intensity until 60% is achieved Session 10-12: Continue with previous training + treadmill training
Study: NCT03241888

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Megestrol Acetate
Description: At a dosage of 160 mg/day
Study: NCT00843960

Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: behavioral adaptation and symptom management
Description: behavioral adaptation and symptom management
Study: NCT03241888

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Megestrol Acetate
Description: At a dosage of 160 mg/day

Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Levonorgestrel-releasing Intrauterine System(LNG-IUS)
Description: Active ingredient: levonorgestrel 52mg. It is a hormone-releasing T-shaped intrauterine system.

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Levonorgestrel-releasing Intrauterine System(LNG-IUS)
Description: Active ingredient: levonorgestrel 52mg. It is a hormone-releasing T-shaped intrauterine system.
Study: NCT01140204

Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Implantation of a bare metal stent
Description: Bare Metal Stent

Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Implantation of a bare metal stent
Description: Bare Metal Stent

Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Implantation of a bare metal stent
Description: Bare Metal Stent

Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Implantation of a bare metal stent
Description: Bare Metal Stent
Study: NCT00314782

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: ZD4054 (Zibotentan)
Description: oral tablet

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: ZD4054 (Zibotentan)
Description: oral tablet

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: ZD4054 (Zibotentan)
Description: oral tablet

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Docetaxel
Description: intravenous infusion

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Docetaxel
Description: intravenous infusion

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Docetaxel
Description: intravenous infusion

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Docetaxel
Description: intravenous infusion

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Placebo
Study: NCT01935648

Intervention type: DRUG
Intervention: Ropivacaine
Study: NCT03358095

Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Tannenbaum Fr 10 stent or WallFlex stent
Description: A plastic or metallic endoprosthesis is placed to the biliary ducts.
Study: NCT03457090

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Examination : a TCD and Trans-Thoracic Echocardiography
Description: Examination that involves the completion of a TCD and an TTE (Trans-Thoracic Echocardiography) :~* To reports clinical parameters at the time of the examination : ECG data: sinus rhythm, atrial or ventricular arrhythmia, state of consciousness, heart rate, O2 saturation~* To review of pharmacological parameters at the time of the examination : presence of sedation; presence, type and dose of catecholamines.~* To collect biological data from the day of the examination : Partial Pressure of O2, PaCO2 (partial pressure) and hematocrit~* To collect possible additional examinations : brain scan, EEG. These are non-invasive exams that do not require patient displacement. Only the samples taken by the medical team as part of the treatment will be analyzed.
Study: NCT05338476

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Midazolam
Description: Administered orally.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Midazolam
Description: Administered orally.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Selpercatinib
Description: Administered orally.
Study: NCT02668042

Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: liveness tissue skin
Description: liveness tissue skin safety and effectiveness for the treatment of difficult to heal wounds
Study: NCT02263417

Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Deep Brain Stimulation (DBS) of Gpi

Intervention type: DEVICE
Group type: SHAM_COMPARATOR
Intervention: Deep Brain Stimulation (DBS) of Gpi

Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Deep Brain Stimulation (DBS) of STN

Intervention type: DEVICE
Group type: SHAM_COMPARATOR
Intervention: Deep Brain Stimulation (DBS) of STN
Study: NCT01140204

Intervention type: DEVICE
Group type: PLACEBO_COMPARATOR
Intervention: Implantation of a bare metal stent
Description: Bare Metal Stent
Study: NCT02553733

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Beetroot juice
Description: This beverage contains 0.3 g of inorganic nitrate per 70 ml container, and is bottled and supplied by James White Drinks (UK).

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Beetroot juice placebo
Description: This beverage is identical in look and taste to the Beet-It organic shot, but has the nitrate removed. It is also bottled and supplied by James White Drinks (UK).
Study: NCT04597801

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Alcon
Description: Fluorescein sodium is administered intravenously with a bolus injection of 5 mg per kg of bodyweight 20-40 minutes prior to the planned tumor resection.
Study: NCT04856280

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Kinesiological taping
Description: In KT Group, 6 sessions of KT were applied, starting on the 14th day of the menstrual cycle and 2 times a week for 3 weeks until the cycle ended.

Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Aerobic exercise
Description: In the AE group, walking and climbing stairs were given during the menstrual cycle, 3 days a week, 45 minutes.
Study: NCT03137823

Intervention type: DIAGNOSTIC_TEST
Group type: OTHER
Intervention: throat culture
Description: throat culture - from the tonsills and from the bucal surface
Study: NCT03986892

Intervention type: BEHAVIORAL
Intervention: Physical Activity
Description: Physical Activity

Intervention type: BEHAVIORAL
Intervention: Physical Activity
Description: Physical Activity
Study: NCT01809431

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Intervention
Description: Using a two-group, repeated measures experimental design, this proposed study will test a 14-week intensive intervention on the benefits of breastfeeding, understanding gestational diabetes and risk of progression to prediabetes and type 2 diabetes, nutrition and exercise education, coping skills training, and physical activity (Phase I) and 3 months of continued monthly contact (Phase II) to help overweight women diagnosed with gestational diabetes improve metabolic, clinical, weight, adiposity, health behaviors and self-efficacy.
Study: NCT02212795

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Zabofloxacin 183mg
Description: Zabofloxacin 183mg single dose
Study: NCT00672035

Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Biological: heat-labile enterotoxin of E. coli (LT)
Description: LT patch applied on either the deltoid or the lower back.

Intervention type: BIOLOGICAL
Group type: PLACEBO_COMPARATOR
Intervention: Biological: heat-labile enterotoxin of E. coli (LT)
Description: LT patch applied on either the deltoid or the lower back.

Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Biological: heat-labile enterotoxin of E. coli (LT)
Description: LT patch applied on either the deltoid or the lower back.

Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Biological: heat-labile enterotoxin of E. coli (LT)
Description: LT patch applied on either the deltoid or the lower back.

Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Biological: heat-labile enterotoxin of E. coli (LT)
Description: LT patch applied on either the deltoid or the lower back.

Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Biological: heat-labile enterotoxin of E. coli (LT)
Description: LT patch applied on either the deltoid or the lower back.

Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Biological: heat-labile enterotoxin of E. coli (LT)
Description: LT patch applied on either the deltoid or the lower back.

Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Biological: heat-labile enterotoxin of E. coli (LT)
Description: LT patch applied on either the deltoid or the lower back.

Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Biological: heat-labile enterotoxin of E. coli (LT)
Description: LT patch applied on either the deltoid or the lower back.

Intervention type: BIOLOGICAL
Group type: PLACEBO_COMPARATOR
Intervention: Biological: heat-labile enterotoxin of E. coli (LT)
Description: LT patch applied on either the deltoid or the lower back.
Study: NCT03196778

Intervention type: RADIATION
Group type: EXPERIMENTAL
Intervention: Low Dose Radiotherapy
Description: Patients will receive 10 fractions of very low dose hemi-body radiation, delivered, twice per week, over five weeks
Study: NCT00693147

Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Total Thyroidectomy
Description: Late postoperative course of patients with mini Video Assisted Thyroidectomy (miVAT) versus classic Thyroidectomy (T)

Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Total Thyroidectomy
Description: Late postoperative course of patients with mini Video Assisted Thyroidectomy (miVAT) versus classic Thyroidectomy (T)
Study: NCT03611686

Intervention type: DRUG
Intervention: Local chemotherapy
Description: Local chemotherapy will be administrated according to local recommendation
Study: NCT02526290

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Intranasal Lacrimal Neurostimulator (Oculeve)
Description: Neurostimulation device
Study: NCT03185026

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Interventional group : PEPSUI psychoeducational program
Description: The program includes 10 weekly, 2-hours sessions led by two trained animators (nurse, medical doctor/psychologist), each focusing on a specific theme or skill :~1. Education on suicidal behavior (clinic and epidemiology), and conceptualization of the phenomenon on a matrix~2. Education on the suicidal crisis, identification of important life areas and values for the patient, experimentation on the way to use the matrix as a decision-making tool.~3. and 4) Self-assessment of suicidal ideations, coping strategies based on suicide ideation intensity and emotional tension (acceptation, distress tolerance, personal aid kit, and emergency care)~5) Stress-diathesis model of suicidal behavior, innovating cognitive skills (defusion), and valued actions 6) Stress factors (psychiatric diseases and negative life events), resilience, and contact with present moment 7) Suicidal vulnerability, personal strengths 8) Social support, skills to create quality relationships

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Relaxation group
Description: Participants will be included in a standardized relaxation program, consisting of 10 weekly sessions lasting 2 hours. There will be 2 therapists for each patients group. Abdominal and muscular relaxation skills will be experimented.
Study: NCT03097640

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: CHAMP
Description: CHAMP team members visit patients in the ED and on inpatient floors. Along with the patient's input, the team develops an Individualized Care Plan outlining the patient's medical and social history and providing recommendations to other providers on specific aspects of their care. Care plans are reviewed with patients on an individual basis and reviewed periodically by the CHAMP providers. CHAMP-enrolled participants are scheduled for physician and social worker follow-up appointments at the CHAMP clinic; this time is used to provide intensive case management, medical care, and psychosocial support.
Study: NCT03624075

Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: application of kinesio taping
Description: application of kinesio taping in the rectus femoris muscle and in the medial and lateral region of the knee

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: application of kinesio taping
Description: application of kinesio taping in the rectus femoris muscle and in the medial and lateral region of the knee
Study: NCT02212795

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Zabofloxacin 183mg
Description: Zabofloxacin 183mg single dose

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Zabofloxacin 183mg
Description: Zabofloxacin 183mg single dose

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Levofloxacin 250mg
Description: Levofloxacin 250mg single dose

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Levofloxacin 250mg
Description: Levofloxacin 250mg single dose

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Levofloxacin 250mg
Description: Levofloxacin 250mg single dose

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Zabofloxacin 367mg
Description: Zabofloxacin 367mg single dose

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Zabofloxacin 367mg
Description: Zabofloxacin 367mg single dose

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Zabofloxacin 367mg
Description: Zabofloxacin 367mg single dose
Study: NCT01163331

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Singing Therapy
Description: Singing therapy as a way to improve voice quality
Study: NCT04223973

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Medtrum A7+ insulin Pump
Description: Use of the Medtrum pump during 3 months in combination with a CGM (Continuous Glucose Measurement)

Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Lab A1C
Description: Measure of Lab A1C at baseline and end of study

Intervention type: BIOLOGICAL
Group type: ACTIVE_COMPARATOR
Intervention: Lab A1C
Description: Measure of Lab A1C at baseline and end of study
Study: NCT04368676

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Sudarshan Kriya Yoga (SKY)
Description: The SKY program is a standardized, easy to learn sequential breathing yoga consisting of regulated breathing techniques followed by a timed rhythmic breathing practice. Participants will learn various exercises including rhythmic breathing, gentle yoga, and guided meditation.

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Health Enhancement Program
Description: HEP is a structured group program designed to help participants with information and instruction how to lead a healthier life. Participants will be provided psychoeducation and support regarding healthy active living using techniques like music therapy, diet control, exercise, and monitoring these via journaling.
Study: NCT02888613

Intervention type: PROCEDURE
Group type: OTHER
Intervention: mini laparotomy
Description: The patient will be positioned supine. After induction of general anesthesia, a median umbilical incision will be performed. The average length of the incision of the laparotomy will be 10 cm (8-12 cm). The small intestine will be then mobilized medially and held by an orthostatic retractor. Arterial dissection and control as well as bypasses will be performed according to the conventional technique. In case of occlusive disease of the iliac arteries, femoral site will be selected to achieve the distal anastomoses of the bifurcated prosthetic graft.

Intervention type: PROCEDURE
Group type: OTHER
Intervention: mini lumbotomy
Description: After induction of general anesthesia, the patient will be positioned in right lateral decubitus at 45° of the table plane. The incision will be performed from the tip of the eleventh rib with a slightly sloping path to the outer edge of the rectus muscle. The average length of the incision of the laparotomy will be 10 cm (8-12 cm).~Abdominal aorta will be approached retroperitoneally. Arterial dissection and control as well as bypasses will be performed according to the conventional retroperitoneal technique. In case of occlusive disease of the iliac arteries, femoral site will be selected to achieve the distal anastomoses of the bifurcated prosthetic graft.
Study: NCT05169255

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Antibiotic administration
Description: Individuals received either azithromycin or amoxicillin for 3 or 7 days

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Antibiotic administration
Description: Individuals received either azithromycin or amoxicillin for 3 or 7 days